These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 16761484)
1. Intestinal necrosis in a patient with rheumatoid arthritis receiving anti-TNF treatment. Ruppert M; De Clerck L; van Offel J; Hubens G; Balliu L; Vaneerdeweg W Acta Chir Belg; 2006; 106(2):225-7. PubMed ID: 16761484 [TBL] [Abstract][Full Text] [Related]
2. Should anti-tumor necrosis factor-alpha be the first therapy for rheumatoid vasculitis? Garcia-Porrua C; Gonzalez-Gay MA; Quevedo V J Rheumatol; 2006 Feb; 33(2):433; author reply 433-4. PubMed ID: 16465676 [No Abstract] [Full Text] [Related]
3. Comparison of the clinical characteristics of vasculitis occurring during anti-tumor necrosis factor treatment or not in rheumatoid arthritis patients. A systematic review of 2707 patients, 18 vasculitis. Guignard S; Gossec L; Bandinelli F; Dougados M Clin Exp Rheumatol; 2008; 26(3 Suppl 49):S23-9. PubMed ID: 18799049 [TBL] [Abstract][Full Text] [Related]
4. Improved rheumatoid digital vasculitis in a patient treated with TNFalpha agent blocking (infliximab). Benucci M; Li Gobbi F; Saviola G; Manfredi M Rheumatol Int; 2008 Oct; 28(12):1253-5. PubMed ID: 18493770 [TBL] [Abstract][Full Text] [Related]
5. Rheumatoid vasculitis treated with infliximab. van der Bijl AE; Allaart CF; Van Vugt J; Van Duinen S; Breedveld FC J Rheumatol; 2005 Aug; 32(8):1607-9. PubMed ID: 16078342 [TBL] [Abstract][Full Text] [Related]
6. Use of infliximab in a patient with rheumatoid arthritis and chronic hepatitis B. Doubrawa E; Ricca RA; Malucelli TO; Pizzol VI; Barros DH; Paiva ES Rev Bras Reumatol; 2012 Aug; 52(4):653-5. PubMed ID: 22885430 [TBL] [Abstract][Full Text] [Related]
7. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. Lipsky PE; van der Heijde DM; St Clair EW; Furst DE; Breedveld FC; Kalden JR; Smolen JS; Weisman M; Emery P; Feldmann M; Harriman GR; Maini RN; N Engl J Med; 2000 Nov; 343(22):1594-602. PubMed ID: 11096166 [TBL] [Abstract][Full Text] [Related]
8. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents. Strangfeld A; Listing J; Herzer P; Liebhaber A; Rockwitz K; Richter C; Zink A JAMA; 2009 Feb; 301(7):737-44. PubMed ID: 19224750 [TBL] [Abstract][Full Text] [Related]
9. Development of myeloperoxidase-antineutrophil cytoplasmic antibody-associated renal vasculitis in a patient receiving treatment with anti-tumor necrosis factor-α. Hirohama D; Hoshino J; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Takemoto F; Ubara Y; Hara S; Ohashi K; Takaichi K Mod Rheumatol; 2010 Dec; 20(6):602-5. PubMed ID: 20680377 [TBL] [Abstract][Full Text] [Related]
10. Infliximab treatment of rheumatoid arthritis. Maini SR Rheum Dis Clin North Am; 2004 May; 30(2):329-47, vii. PubMed ID: 15172044 [TBL] [Abstract][Full Text] [Related]
15. Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results. Braun-Moscovici Y; Markovits D; Rozin A; Toledano K; Nahir AM; Balbir-Gurman A Isr Med Assoc J; 2008 Apr; 10(4):277-81. PubMed ID: 18548981 [TBL] [Abstract][Full Text] [Related]
16. Infliximab: a new treatment for rheumatoid arthritis. Emery P Hosp Med; 2001 Mar; 62(3):150-2. PubMed ID: 11291464 [TBL] [Abstract][Full Text] [Related]
17. Development of type 1 diabetes mellitus in a patient with rheumatoid arthritis receiving anti-tumor necrosis factor alpha. Richez C; Blanco P; Gin H; Schaeverbeke T Clin Exp Rheumatol; 2006; 24(5):607. PubMed ID: 17181936 [No Abstract] [Full Text] [Related]